Skip to content

The full registry

Every registered trial

Every trial of a classic psychedelic or entactogen on the US federal registry, plus ketamine where the indication is psychiatric. Sorted so anything recruiting comes first.

1,033
Trials in the registry
218
Recruiting
96
In Phase 3
180
With results posted
TrialStatusPhaseSubstanceSites
Positioning of Esketamine Treatment in the Real-world Management of DepressionNCT06103760 · Royal North Shore HospitalRecruitingPhase 4ketamine1
Esketamine Versus Crisis Response Planning Versus Optimized Treatment as Usual for Suicide Prevention: A Pragmatic Controlled Trial in Two Brazilian CitiesNCT07120477 · University of Sao PauloRecruitingPhase 4ketamine1
Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm RepairNCT04894864 · University of CreteRecruitingPhase 4ketamine1
Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant DepressionNCT06278779 · The George InstituteRecruitingPhase 4ketamine7
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma PatientsNCT06903819 · Texas Tech University Health Sciences CenterRecruitingPhase 4ketamine2
Esketamine With or Without Integration Therapy for Treatment-Resistant DepressionNCT07369102 · University of Puerto RicoRecruitingPhase 4ketamine2
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With DepressionNCT05450432 · Massachusetts General HospitalRecruitingPhase 4ketamine1
Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General AnesthesiaNCT06853431 · Second Affiliated Hospital of Wenzhou Medical UniversityRecruitingPhase 4ketamine2
Neural Circuit Effects of Ketamine in DepressionNCT06213324 · Icahn School of Medicine at Mount SinaiRecruitingPhase 4ketamine1
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECTNCT05655754 · Medical University of ViennaRecruitingPhase 4ketamine1
Analgesic Efficacy of Intravenous Ketamine as a Continuous Infusion vs PCA in the Management of Acute Postoperative Pain in Major Orthopedic Surgery.NCT06774274 · Universidad de AntioquiaRecruitingPhase 4ketamine1
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSDNCT06414356 · Margaux M. Salas, PhDRecruitingPhase 4ketamine1
ECT with Ketamine Anesthesia Vs High Intensity Ketamine with ECT Rescue for Treatment-Resistant DepressionNCT03272698 · University of SaskatchewanRecruitingPhase 4ketamine1
IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric EDNCT05934669 · University of OklahomaRecruitingPhase 4ketamine1
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderNCT07570654 · COMPASS PathwaysRecruitingPhase 2 / Phase 3psilocybin1
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderNCT06793397 · Cybin IRL LimitedRecruitingPhase 3psilocybin68
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant DepressionNCT07226232 · VA Office of Research and DevelopmentRecruitingPhase 3psilocybin5
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive DisorderNCT06247839 · Sharmin GhaznaviRecruitingPhase 3psilocybin1
InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpressionNCT06781697 · Sunnybrook Health Sciences CentreRecruitingPhase 3ketamine1
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689 · Definium Therapeutics US, Inc.RecruitingPhase 3lsd30
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence StudyNCT06713616 · Yale UniversityRecruitingPhase 3ketamine8
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderNCT07227454 · Janssen Research & Development, LLCRecruitingPhase 3ketamine35
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant DepressionNCT07716098 · Janssen Research & Development, LLCRecruitingPhase 3ketamine4
Ketamine Treatment of Youth Suicide AttemptersNCT04763343 · Tatiana Falcone, MDRecruitingPhase 3ketamine1
Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive DisorderNCT07703722 · Khyber Medical University PeshawarRecruitingPhase 3psilocybin3
Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)NCT07063862 · Bruyère Health Research Institute.RecruitingPhase 3psilocybin7
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive SymptomsNCT07638553 · Centre Hospitalier Universitaire de NīmesRecruitingPhase 3psilocybin8
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use DisorderNCT07118839 · VA Office of Research and DevelopmentRecruitingPhase 2 / Phase 3mdma2
Understanding and Treating Suicidal Ideation With KetamineNCT06891300 · The Royal's Institute of Mental Health ResearchRecruitingPhase 2 / Phase 3ketamine1
Ketamine Augmentation of ECT in Treatment-Resistant DepressionNCT07088380 · Università Vita-Salute San RaffaeleRecruitingPhase 3ketamine1
MDMA-assisted Massed Prolonged Exposure for PTSDNCT06117306 · Healing BreakthroughRecruitingPhase 3mdma1
Nebulized Ketamine for the Treatment of Major Depressive DisorderNCT06752759 · Theresa Jacob, PhD, MPHRecruitingPhase 3ketamine1
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment FailureNCT05603104 · Dr. Inge WinterRecruitingPhase 3ketamine1
Psilocybin Therapy in Advanced CancerNCT05398484 · NYU Langone HealthRecruitingPhase 2 / Phase 3psilocybin2
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.NCT05973851 · Dr. Inge WinterRecruitingPhase 3ketamine12
Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression PatientsNCT06508710 · Assistance Publique - Hôpitaux de ParisRecruitingPhase 3ketamine4
Ketamine & Crisis Response Plan for Suicidal Ideation in the EDNCT05696691 · The University of Texas Health Science Center at San AntonioRecruitingPhase 2 / Phase 3ketamine1
Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral InjuryNCT06394284 · Herzog HospitalRecruitingPhase 3mdma1
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant DepressionNCT07211438 · Centre for Addiction and Mental HealthRecruitingPhase 2psilocybin2
MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress DisorderNCT05790239 · Stephen Robert MarderRecruitingPhase 2mdma2
MDMA-Assisted CBCT for PTSD vs CBCT RCTNCT06044675 · RemedyRecruitingPhase 2mdma1
Neurobiology of SuicideNCT02543983 · National Institute of Mental Health (NIMH)RecruitingPhase 2ketamine1
Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia NervosaNCT07169747 · Region SkaneRecruitingPhase 2psilocybin1
Psilocybin-Assisted Therapy for Intergenerational TraumaNCT06899165 · Rachel YehudaRecruitingPhase 2psilocybin1
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyNCT06200155 · M.D. Anderson Cancer CenterRecruitingPhase 2psilocybin1
Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUDNCT06349083 · NYU Langone HealthRecruitingPhase 2psilocybin1
Pilot Study of RR-HNK in OCDNCT06575075 · Carolyn RodriguezRecruitingPhase 1 / Phase 2ketamine1
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and SuicidalityNCT06706232 · The University of Texas Health Science Center, HoustonRecruitingPhase 2psilocybin1
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer SurvivorsNCT06801041 · M.D. Anderson Cancer CenterRecruitingPhase 2psilocybin1
Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety DisorderNCT06969170 · Claudio N SoaresRecruitingPhase 2psilocybin1
Investigation to Understand and Optimize PsilocybinNCT06512194 · Charles RaisonRecruitingPhase 2psilocybin1
Psilocybin to Treat Depression in Spinal Cord InjuryNCT07251491 · James J. Peters Veterans Affairs Medical CenterRecruitingPhase 1 / Phase 2psilocybin1
Psilocybin Therapy for Depression in Parkinson's DiseaseNCT06455293 · Joshua Woolley, MD, PhDRecruitingPhase 2psilocybin1
Mindfulness-Assisted Psychedelic TherapyNCT06233344 · University of Southern CaliforniaRecruitingPhase 2psilocybin1
Psilocybin in Cancer Pain StudyNCT06001749 · Yvan Beaussant, MD, MSciRecruitingPhase 2psilocybin1
Effects of a Sigle Dose of Ayahuasca in Patients With Psychogenic Non-epileptic Seizures: an Open Label Clinical TrialNCT07747324 · University of Sao PauloRecruitingPhase 1 / Phase 2dmt1
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)NCT06512220 · Centre for Addiction and Mental HealthRecruitingPhase 2psilocybin1
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)NCT06518720 · Centre for Addiction and Mental HealthRecruitingPhase 2psilocybin1
Ecstasy to Alleviate SEvere Chronic Neuropathic Pain TrialNCT07301632 · Unity Health TorontoRecruitingPhase 2mdma1
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)NCT07569198 · Joshua RosenblatRecruitingPhase 2ketamine1
Effects of Psilocybin on Electrophysiology and the Dynamic Content of ThoughtNCT05301608 · Johns Hopkins UniversityRecruitingPhase 1 / Phase 2psilocybin1
A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and AnxietyNCT06820723 · Ohio State UniversityRecruitingPhase 2psilocybin1
Psilocybin-Assisted Therapy for Physician Well-Being and BurnoutNCT06814522 · University of California, San DiegoRecruitingPhase 1 / Phase 2psilocybin1
Psilocybin Efficacy With or Without Pimavanserin PretreatmentNCT07610135 · Johns Hopkins UniversityRecruitingPhase 1 / Phase 2psilocybin1
The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseNCT07610369 · Yale UniversityRecruitingPhase 2psilocybin1
Tolerability of MDMA in SchizophreniaNCT05770375 · Anya Bershad, MD, PhDRecruitingPhase 1 / Phase 2mdma1
Outpatient Buprenorphine Induction With Psilocybin for Opioid Use DisorderNCT06067737 · Johns Hopkins UniversityRecruitingPhase 2psilocybin1
Inhaled DMT for Major Depressive DisorderNCT07562191 · Universidade Federal do Rio Grande do NorteRecruitingPhase 2dmt5
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant DepressionNCT06511908 · National Institute of Mental Health (NIMH)RecruitingPhase 2ketamine1
Psilocybin on Brain Mechanisms of Motivation in OUDNCT06810310 · University of PennsylvaniaRecruitingPhase 2psilocybin1
Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury.NCT05732155 · HaEmek Medical Center, IsraelRecruitingPhase 2mdma1
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSDNCT06902974 · Sunstone MedicalRecruitingPhase 2psilocybin1
MDMA Therapy in Veterans With PTSDNCT07569159 · Sunstone MedicalRecruitingPhase 2mdma1
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderNCT05452772 · Johns Hopkins UniversityRecruitingPhase 2psilocybin3
Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSDNCT06386003 · Unity Health TorontoRecruitingPhase 2psilocybin1
Mindfulness-based Psilocybin Therapy for PTSDNCT07104916 · Anthony P KingRecruitingPhase 2psilocybin1
Ketamine for Combined Depression and Alcohol Use DisorderNCT06090422 · University Hospital of North NorwayRecruitingPhase 1 / Phase 2ketamine1
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Caregivers of Patients With Advanced CancerNCT07048743 · University Health Network, TorontoRecruitingPhase 2psilocybin1
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit PatientsNCT07639359 · Hospital Italiano de Buenos AiresRecruitingPhase 2ketamine2
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy VolunteersNCT06626139 · Robin Carhart-Harris, PhD, MARecruitingPhase 2psilocybin1
Subjective Experience Following PsilocybinNCT06768944 · University of CalgaryRecruitingPhase 2psilocybin1
MDMA-Assisted Massed Exposure Therapy for PTSDNCT07288151 · Emory UniversityRecruitingPhase 2mdma1
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung CancerNCT07216404 · Alan DavisRecruitingPhase 2psilocybin1
Psilocybin Therapy for Psychological Distress in Palliative PatientsNCT06782724 · University Medical Center GroningenRecruitingPhase 2psilocybin4
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal EffectsNCT05786066 · Yale UniversityRecruitingPhase 2ketamine1
MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant OtherNCT05584826 · Sunstone MedicalRecruitingPhase 2mdma1
Ketamine Alcohol (in Treatment-Resistant Depression)NCT02122562 · Mark NiciuRecruitingPhase 2ketamine1
Ketamine, SGB and Combination Treatment for TBI-associated Headache or PTSDNCT06608277 · Northwestern UniversityRecruitingPhase 2ketamine3
LSD Treatment for Persons With Alcohol Use DisorderNCT05474989 · Felix MuellerRecruitingPhase 2lsd2
Lysergic Acid Diethylamide (LSD) in Palliative CareNCT05883540 · University Hospital, Basel, SwitzerlandRecruitingPhase 2lsd4
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)NCT05940324 · Stanford UniversityRecruitingPhase 2ketamine1
Cancer Related Major Depression Treated With a Single Dose of PsilocybinNCT06319378 · Section for Affective Disorders; Northern Stockholm PsychiatryRecruitingPhase 2psilocybin4
A Phase 2A Trial of DT402 for Autism Spectrum DisorderNCT07303907 · Definium Therapeutics US, Inc.RecruitingPhase 2mdma1
A Randomized Neuroimaging Trial of Psilocybin in DepressionNCT06072898 · Sunnybrook Health Sciences CentreRecruitingPhase 2psilocybin1
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory DepressionNCT06898606 · Federal University of Latin American IntegrationRecruitingPhase 1 / Phase 2psilocybin1
MDMA for Co-occurring PTSD and OUD After ChildbirthNCT05219175 · University of New MexicoRecruitingPhase 2mdma1
Ketamine for Opioid Use DisorderNCT06943859 · University of Maryland, BaltimoreRecruitingPhase 2ketamine1
Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 EventsNCT07469098 · Sheba Medical CenterRecruitingPhase 2mdma2
Imaging Depression in Parkinson's DiseaseNCT06402955 · Yale UniversityRecruitingPhase 2ketamine1
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)NCT05783817 · Carolyn RodriguezRecruitingPhase 2mdma1
Study of Psilocybin for Anorexia in Young AdultsNCT06399263 · Marissa Raymond-Flesch, MD, MPHRecruitingPhase 2psilocybin2
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderNCT07072728 · Psyence Australia Pty LtdRecruitingPhase 2psilocybin3
RCT of Psilocybin-assisted CBT for DepressionNCT07281352 · University of California, Los AngelesRecruitingPhase 1 / Phase 2psilocybin1
Psilocybin for Opioid Use Disorder (OUD)NCT06796062 · NYU Langone HealthRecruitingPhase 2psilocybin5
MDMA in Borderline Personality DisorderNCT06683014 · Yale UniversityRecruitingPhase 2mdma1
State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing TraumaNCT06888128 · Baylor College of MedicineRecruitingPhase 2psilocybin1
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or BehaviorNCT07193901 · Sichuan Purity Pharmaceutical Technology Co., Ltd.RecruitingPhase 2ketamine8
Ayahuasca, Esketamine and PTSDNCT07317206 · University of Sao PauloRecruitingPhase 2ketamine, dmt1
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid DepressionNCT06419439 · VA Office of Research and DevelopmentRecruitingPhase 2ketamine1
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical TrialNCT06480500 · University Health Network, TorontoRecruitingPhase 2ketamine1
Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use DisorderNCT06969937 · Dr. med. Marcus HerdenerRecruitingPhase 2ketamine1
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid MedicationNCT05585229 · University of British ColumbiaRecruitingPhase 2psilocybin1
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator TrialNCT06405607 · University of IowaRecruitingPhase 2psilocybin, ketamine1
Psilocybin rTMS for Treatment Resistant DepressionNCT06132178 · University of Texas at AustinRecruitingPhase 2psilocybin1
Pragmatic Trial of Psilocybin Therapy in Palliative CareNCT05403086 · Charles S. Grob, M.D.RecruitingPhase 2psilocybin, ketamine5
Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCDNCT04882839 · Beersheva Mental Health CenterRecruitingPhase 2psilocybin1
Psilocybin Microdosing With Psychotherapy for Treatment-Resistant DepressionNCT07183748 · Beersheva Mental Health CenterRecruitingPhase 2psilocybin1
Wellcome Leap Psilocybin for OUDNCT06786325 · Anna Rose Childress, Ph.D.RecruitingPhase 2psilocybin1
Intravenous Ketamine for Treatment-Resistant DepressionNCT06668571 · Mayo ClinicRecruitingPhase 2ketamine1
MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress DisorderNCT05837845 · Patricia SuppesRecruitingPhase 2mdma1
A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With DepressionNCT06597695 · Juliana Zambrano, MD, MPHRecruitingPhase 1 / Phase 2ketamine1
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of DepressionNCT06559826 · Icahn School of Medicine at Mount SinaiRecruitingPhase 2ketamine1
Dose Optimization of MDMA-Assisted Therapy for PTSDNCT06418178 · Bronx VA Medical CenterRecruitingPhase 2mdma1
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive DisorderNCT06592833 · Icahn School of Medicine at Mount SinaiRecruitingPhase 2psilocybin1
Enhancing Week-long Psychological Treatment for PTSD With KetamineNCT05737693 · Yale UniversityRecruitingPhase 2ketamine2
LSD to Improve Cluster Headache Impact TrialNCT05477459 · Radboud University Medical CenterRecruitingPhase 2lsd2
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAINNCT06731335 · Unity Health TorontoRecruitingPhase 2psilocybin2
Pharmacologic Treatment Augmentation in Chronic DepressionNCT06410599 · University Hospital TuebingenRecruitingPhase 2ketamine2
Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept StudyNCT06225232 · McMaster UniversityRecruitingPhase 2psilocybin1
MDMA for AUD/PTSD ComorbidityNCT05943665 · Carolina L Haass-KofflerRecruitingPhase 2mdma1
Lysergic Acid Diethylamide (LSD) as Treatment for Cluster HeadacheNCT03781128 · University Hospital, Basel, SwitzerlandRecruitingPhase 2lsd1
Psilocybin for Hospitalized Patients with Treatment-resistant DepressionNCT06378229 · University Hospital, GhentRecruitingPhase 2psilocybin1
Psilocybin-Assisted Therapy for Severe Alcohol Use DisorderNCT06160232 · Brugmann University HospitalRecruitingPhase 2psilocybin1
Psilocybin-Assisted Psychotherapy for Alcohol Use DisorderNCT05995769 · University of CalgaryRecruitingPhase 2psilocybin1
The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)NCT06070649 · Yale UniversityRecruitingPhase 1dmt1
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive DisorderNCT03065335 · National Institute of Mental Health (NIMH)RecruitingPhase 1ketamine1
The RECAP2 Study: Midazolam and PsilocybinNCT06692192 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1
Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsNCT07516405 · University of Colorado, DenverRecruitingPhase 1psilocybin6
The ENHANCE Study: taVNS and PsilocybinNCT05866471 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1
Psilocybin in Chronic Low Back Pain and DepressionNCT06355414 · Johns Hopkins UniversityRecruitingPhase 1psilocybin1
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.NCT07347405 · Francisco A MorenoRecruitingPhase 1psilocybin1
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the BrainNCT05265546 · University of California, BerkeleyRecruitingPhase 1psilocybin1
Adjunctive Effects of Psilocybin and a Formulation of BuprenorphineNCT04161066 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)NCT06160284 · Yale UniversityRecruitingPhase 1psilocybin1
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant DepressionNCT06480201 · Texas A&M UniversityRecruitingPhase 1ketamine2
MDMA Assisted Therapy for BNNCT07542145 · Icahn School of Medicine at Mount SinaiRecruitingPhase 1mdma1
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major DepressionNCT03973268 · National Institute of Mental Health (NIMH)RecruitingPhase 1ketamine1
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in HumansNCT06671977 · Deepak C. D'SouzaRecruitingPhase 1dmt1
A Study of Psychedelics in Healthy Older Adults With Low Well-beingNCT07386730 · Jennifer MitchellRecruitingPhase 1psilocybin1
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress DisorderNCT07506395 · University of New MexicoRecruitingPhase 1psilocybin1
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine ResponseNCT05915013 · Yale UniversityRecruitingPhase 1ketamine1
HNC: Human Neural Circuits Electrophysiology During CognitionNCT05962424 · Stanford UniversityRecruitingPhase 1ketamine1
Study of Psilocybin Assisted Psychotherapy to Address Fear of RecurrenceNCT06430541 · University of Colorado, DenverRecruitingPhase 1psilocybin2
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency DepartmentNCT06085937 · Lindsay Maguire, MDRecruitingPhase 1ketamine2
MDMA-Assisted Therapy for Mental Healthcare ProvidersNCT07102576 · Rachel YehudaRecruitingPhase 1mdma1
Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy ParticipantsNCT07494214 · University Hospital, Basel, SwitzerlandRecruitingPhase 1mdma1
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic EffectsNCT07490353 · Medical University of ViennaRecruitingPhase 1psilocybin1
Psilocybin-assisted Treatment for Cannabis Use DisorderNCT06660381 · Johns Hopkins UniversityRecruitingPhase 1psilocybin1
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage CancerNCT06818994 · Gustavo VazquezRecruitingPhase 1psilocybin1
Open-Label Psilocybin Study in Transdiagnostic PopulationNCT06442423 · Yale UniversityRecruitingPhase 1psilocybin1
Acute Effects of Intravenous 5-MeO-DMT in Healthy ParticipantsNCT07444788 · University Hospital, Basel, SwitzerlandRecruitingPhase 1dmt1
Investigation of Psychedelic Effects in Psychoactive SubstancesNCT06772753 · Johns Hopkins UniversityRecruitingPhase 1psilocybin, mdma, dmt1
Psychedelic Healing: Adjunct Therapy Harnessing Opened MalleabilityNCT07053917 · Johns Hopkins UniversityRecruitingPhase 1psilocybin1
Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersNCT07079930 · Hadassah Medical OrganizationRecruitingPhase 1psilocybin1
Treatment of Persisting Symptoms After Concussion With Psilocybin Assisted TherapyNCT06615908 · University of CalgaryRecruitingPhase 1psilocybin1
Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based ProgramsNCT06815653 · University College, LondonRecruitingPhase 1psilocybin1
Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older AdultsNCT06367738 · University of California, BerkeleyRecruitingPhase 1psilocybin1
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)NCT06989957 · Johns Hopkins UniversityRecruitingPhase 1psilocybin, mdma1
Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of ConsciousnessNCT06796361 · University Hospital, Basel, SwitzerlandRecruitingPhase 1psilocybin1
Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy ParticipantsNCT06899334 · University Hospital, Basel, SwitzerlandRecruitingPhase 1lsd, psilocybin, dmt1
The Neurobiological Effect of 5-HT2AR ModulationNCT03289949 · Gitte Moos KnudsenRecruitingPhase 1psilocybin1
Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy SubjectsNCT06511947 · GH Research Ireland LimitedRecruitingPhase 1dmt1
Psilocybin Administration With 5-HT1a BlockadeNCT07565493 · Johns Hopkins UniversityRecruitingEarly Phase 1psilocybin1
Effects of Psilocybin in Patients With Amyotrophic Lateral SclerosisNCT06656702 · Johns Hopkins UniversityRecruitingEarly Phase 1psilocybin1
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of KetamineNCT06788249 · University of PennsylvaniaRecruitingEarly Phase 1ketamine1
Psilocybin as a Treatment for Chronic Pain in SmokersNCT07118332 · Yale UniversityRecruitingEarly Phase 1psilocybin2
Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSDNCT07737054 · Tel-Aviv Sourasky Medical CenterRecruitingEarly Phase 1psilocybin1
Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin.NCT07732166 · Pontifícia Universidade Católica do Rio de JaneiroRecruitingEarly Phase 1psilocybin1
Mechanistic Studies of Psilocybin in Headache DisordersNCT06464367 · Yale UniversityRecruitingEarly Phase 1psilocybin1
MDMA-assisted Therapy for FibromyalgiaNCT06066853 · Spaulding Rehabilitation HospitalRecruitingEarly Phase 1mdma1
Psilocybin for Prolonged Grief DisorderNCT06724289 · University of VirginiaRecruitingEarly Phase 1psilocybin1
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With KetamineNCT05327699 · Emory UniversityRecruitingEarly Phase 1ketamine1
Personalized DBS Targeting for Treating DepressionNCT06784388 · Second Affiliated Hospital, Zhejiang University, School of MedicineRecruitingEarly Phase 1ketamine1
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's DiseaseNCT04123314 · Johns Hopkins UniversityRecruitingEarly Phase 1psilocybin1
Psilocybin-facilitated Treatment for Chronic PainNCT05068791 · University of Alabama at BirminghamRecruitingEarly Phase 1psilocybin1
Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic StudyNCT07247968 · Min SuRecruitingEarly Phase 1ketamine2
PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harmNCT06798636 · Imperial College LondonRecruitingEarly Phase 1psilocybin1
Psilocybin for Methamphetamine AddictionNCT06899594 · Kevin MurnaneRecruitingEarly Phase 1psilocybin1
Cognitive Training as an Adjunct to Ketamine in Real-world ClinicsNCT06526078 · University of PittsburghRecruitingNot applicableketamine3
The OBSERVE ProtocolNCT06725277 · Yale UniversityRecruitingN/Aketamine8
Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant DepressionNCT07563868 · Massachusetts General HospitalRecruitingNot applicableketamine2
Working Mechanisms and Effectiveness of IV Ketamine-assisted Psychotherapy on Depression in TRD ClientsNCT07706478 · SenzRecruitingN/Aketamine1
Mapping Ibogaine Neural Dynamics in Opioid Use DisorderNCT07226570 · University of California, IrvineRecruitingN/Aibogaine1
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1NCT07528014 · Salma Health, Inc.RecruitingN/Aketamine2
Belief Updating in Treatment Resistant DepressionNCT05577247 · Assistance Publique - Hôpitaux de ParisRecruitingN/Aketamine1
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health TreatmentsNCT06997549 · NeuroneticsRecruitingN/Aketamine1
Antidepressant Response of DMT Masked With PropofolNCT06927076 · University Hospital, Basel, SwitzerlandRecruitingNot applicabledmt1
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant DepressionNCT07146503 · Riccardo GuglielmoRecruitingN/Aketamine5
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSDNCT07461532 · Northern Jiangsu People's HospitalRecruitingNot applicablelsd1
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSDNCT07309471 · University Hospital, Basel, SwitzerlandRecruitingNot applicablelsd1
ACT_for Alcohol Use Disorder and DepressionNCT06620276 · Centre hospitalier de l'Université de Montréal (CHUM)RecruitingNot applicableketamine1
University of Iowa Interventional Psychiatry Service Patient RegistryNCT04480918 · Mark NiciuRecruitingN/Aketamine1
Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant DepressionNCT07422519 · Hospital Universitari Vall d'Hebron Research InstituteRecruitingNot applicableketamine1
Ayahuasca, Esketamine and Body Image PerceptionNCT07317219 · University of Sao PauloRecruitingNot applicabledmt1
Ayahuasca, Esketamine and Premenstrual SymptomsNCT07317232 · University of Sao PauloRecruitingNot applicabledmt1
At-Home tDCS as Maintenance TherapyNCT07269964 · Technical University of MunichRecruitingNot applicableketamine2
The Impact of Psilocybin on Pain in Fibromyalgia PatientsNCT06368492 · Maastricht UniversityRecruitingNot applicablepsilocybin2
Ketamine in OCD: Efficacy and Effects on Stress and CognitionNCT05577585 · Medical University of ViennaRecruitingNot applicableketamine1
Metabolic Profiling of Esketamine Treatment in Depressive DisorderNCT07002684 · University of ZagrebRecruitingN/Aketamine1
Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy ControlsNCT06789705 · University Hospital, Basel, SwitzerlandRecruitingNot applicablemdma1
Veteran's Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-LifeNCT06824532 · Albany Research Institute, Inc.RecruitingN/Aketamine1
Ketamine Enhances Analgesia and Mood in Chronic Pain PatientsNCT05985811 · Salem Anaesthesia Pain ClinicRecruitingN/Aketamine1
Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot StudyNCT06732089 · Unity Health TorontoRecruitingN/Aketamine1
Dexmedetomidine and Ketamine in VATS SurgeryNCT03596424 · Ciusss de L'Est de l'Île de MontréalRecruitingNot applicableketamine1
Ketamine Treatment Plans for Chronic ConditionsNCT06038409 · RIVER FoundationRecruitingN/Aketamine1
RIVER At Home Ketamine ProtocolsNCT06070766 · RIVER FoundationRecruitingN/Aketamine2
Study of the Neural Circuits Underlying the Negative Emotional Bias of Depressive Disorders and Their Response to KetamineNCT06630065 · Centre Hospitalier St AnneRecruitingNot applicableketamine1
IV Ketamine vs. IN Esketamine for MDD TRDNCT06488586 · Gustavo VazquezRecruitingN/Aketamine1
Dexmedetomidine-Esketamine Combination on Depression and Anxiety After Laparoscopic Ureteral ReconstructionNCT07753772 · Peking University First HospitalNot yet recruitingPhase 4ketamine1
A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant DepressionNCT07053345 · Janssen Korea, Ltd., KoreaCompletedPhase 4ketamine6
Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal ThoughtsNCT07139106 · New York State Psychiatric InstituteNot yet recruitingPhase 4ketamine1
Biomarker-Guided Antidepressant SelectionNCT07680140 · Weill Medical College of Cornell UniversityNot yet recruitingPhase 4ketamine1
Intranasal Esketamine-dexmedetomidine Combination and Postpartum DepressionNCT07639099 · Peking University First HospitalNot yet recruitingPhase 4ketamine1
IM Ketamine vs Midazolam for Suicidal ER PatientsNCT04640636 · New York State Psychiatric InstituteSuspendedPhase 4ketamine1
Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)NCT04814381 · University Hospital, Clermont-FerrandCompletedPhase 4ketamine14
The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoperative DepressionNCT07179913 · The First Hospital of Jilin UniversityActive, not recruitingPhase 4ketamine1
Postpartum Perineal Pain After Obstetric Anal Sphincter InjuriesNCT03470675 · Northwestern UniversityCompletedPhase 4ketamine1
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for DepressionNCT05615948 · Theresa Jacob, PhD, MPHCompletedPhase 4ketamine1
Ketamine + Cognitive Training for Suicidality in the Medical SettingNCT04578938 · Rebecca PriceActive, not recruitingPhase 4ketamine1
Anhedonia, Development, and Emotions: Phenotyping and TherapeuticsNCT05487885 · Erika ForbesCompletedPhase 4ketamine1
Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt InsertionNCT06060210 · Benha UniversityCompletedPhase 4ketamine1
Comparative Effectiveness of ECT vs. KETAMINE Over the LifespanNCT06034821 · Brigham and Women's HospitalEnrolling by invitationPhase 4ketamine10
Propofol-Enhanced Assessment of Ketamine for Chronic Pain and DepressionNCT06317636 · Stanford UniversityActive, not recruitingPhase 4ketamine1
A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray TreatmentNCT04829318 · Janssen-Cilag Ltd.CompletedPhase 4ketamine59
Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant DepressionNCT05045378 · Taipei Veterans General Hospital, TaiwanCompletedPhase 4ketamine1
Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Depression: A Pilot StudyNCT05950711 · Ohio State UniversityActive, not recruitingPhase 4ketamine1
Ketamine for Postherpetic Neuralgia With DepressionNCT06968624 · Huazhong University of Science and TechnologyNot yet recruitingPhase 4ketamine
Ketamine-assisted Therapy for Advanced GI CancerNCT06077487 · Brian Anderson, MDTerminatedPhase 4ketamine1
A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant DepressionNCT04599855 · Janssen Research & Development, LLCCompletedPhase 4ketamine54
The Impact of Perioperative Ketamine Infusion on Surgical RecoveryNCT04625283 · Vanderbilt University Medical CenterCompletedPhase 4ketamine1
Different Doses of Dexmedetomidine Combined With Esketamine in Women Undergoing Cesarean DeliveryNCT06613243 · Peking University First HospitalCompletedPhase 4ketamine1
Effect of Low-dose Esketamine on Maternal Depression at 3 Years After ChildbirthNCT05698394 · Peking University First HospitalActive, not recruitingPhase 4ketamine4
Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in ParturientsNCT05826327 · Women's Hospital School Of Medicine Zhejiang UniversityUnknown statusPhase 4ketamine1
Ketamine + Cognitive Training for Suicidality in the Medical Setting: PilotNCT04154150 · Rebecca PriceTerminatedPhase 4ketamine1
Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI)NCT04303325 · China Medical University, ChinaUnknown statusPhase 4ketamine1
A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental HealthNCT05604794 · Field Trip HealthCompletedPhase 4ketamine11
Effectiveness of Ketamine Treatment for Three Consecutive Days in DepressionNCT05026203 · Mahidol UniversityCompletedPhase 4ketamine1
Safety and Efficacy Evaluation of S (+) - Ketamine in ChildrenNCT04834427 · Chinese PLA General HospitalUnknown statusPhase 4ketamine1
VA Aripiprazole vs Esketamine for Treatment Resistant DepressionNCT05554627 · VA Office of Research and DevelopmentWithdrawnPhase 4ketamine26
Ketamine Treatment Effects on Synaptic Plasticity in DepressionNCT04091971 · New York State Psychiatric InstituteCompletedPhase 4ketamine1
Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac SurgeryNCT03861988 · Stanford UniversityCompletedPhase 4ketamine1
Low-dose KETamine as an Adjunct to MOrphine for Acute Pain in the EDNCT05422001 · University of AarhusTerminatedPhase 4ketamine1
Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus NephritisNCT05933213 · Xiangya Hospital of Central South UniversityUnknown statusPhase 4mescaline
Clinical Study of Oral Midazolam Combined With Esketamine Administered Intranasally for Pediatric Preoperative SedationNCT05925283 · Second Affiliated Hospital of Wenzhou Medical UniversityUnknown statusPhase 4ketamine1
Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department PatientsNCT03043430 · Brooke Army Medical CenterTerminatedPhase 4ketamine1
Ketamine for Acute Pain Management After TraumaNCT04129086 · The University of Texas Health Science Center, HoustonCompletedPhase 4ketamine1
The Effects of Intraoperative Esketamine on Postoperative Pain and Mood in Patients With Inflammatory Bowel DiseaseNCT05506787 · Jinling Hospital, ChinaCompletedPhase 4ketamine1
Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in DepressionNCT01881763 · Northwell HealthCompletedPhase 4ketamine1
Opioid Free vs Opioid Based Anesthesia for Laparoscopic Sleeve GastrectomyNCT04260659 · Medical University of WarsawCompletedPhase 4ketamine1
Ketamine for Older Adults PilotNCT04504175 · Washington University School of MedicineCompletedPhase 4ketamine5
Preoperative Ketamine and Perioperative DepressionNCT04220125 · Northwestern UniversityWithdrawnPhase 4ketamine
An EEG Study of Intravenous Ketamine for Major Depression DisorderNCT05506462 · Ehave Inc.Unknown statusPhase 4ketamine
Ketamine Versus Fentanyl for Surgical AbortionsNCT04871425 · University of WashingtonCompletedPhase 4ketamine1
The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.NCT03156504 · Mayo ClinicCompletedPhase 4ketamine4
Effects of Esketamine on Postpartum DepressionNCT05229913 · Qinghai UniversityUnknown statusPhase 4ketamine
Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal DepressionNCT03336541 · Peking University First HospitalCompletedPhase 4ketamine1
Tecfidera and the Gut MicrobiotaNCT02471560 · BiogenCompletedPhase 4dmt7
Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive TherapyNCT02579642 · University of AlbertaCompletedPhase 4ketamine2
Intra-nasal vs. Intra-venous Ketamine AdministrationNCT02644629 · Shalvata Mental Health CenterCompletedPhase 4ketamine1
Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency DepartmentNCT04266288 · MercyOne Des Moines Medical CenterCompletedPhase 4ketamine1
A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)NCT03149991 · Massachusetts General HospitalCompletedPhase 4ketamine6
Ketamine Infusion for Adolescent Depression and AnxietyNCT02579928 · Yale UniversityCompletedPhase 4ketamine2
Intranasal Sedation With Dexmedetomidine and Ketamine in Pediatric Dentistry (NASO II)NCT03290625 · Universidade Federal de GoiasCompletedPhase 4ketamine1
The Effect of Ketamine on the Length of Hospital Stay of Patients Hospitalized With Suicidal Ideation.NCT02997722 · Allen RichertTerminatedPhase 4ketamine1
Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)NCT04352621 · University of CincinnatiUnknown statusPhase 4ketamine
Ketamine in the Treatment of Suicidal DepressionNCT01700829 · New York State Psychiatric InstituteCompletedPhase 4ketamine1
Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant DepressionNCT04234776 · University of Sao PauloUnknown statusPhase 4ketamine1
Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or KetamineNCT03788889 · Santa Barbara Cottage HospitalWithdrawnPhase 4ketamine
Research Study for Major Depressive Disorder: Investigation of Glutamate MedicationsNCT00419003 · Baylor College of MedicineCompletedPhase 4ketamine1
Comparison of Ketamine Combine Propofol vs Propofol Anesthesia in Schizophrenia Electroconvulsive TherapyNCT03829124 · Chang Gung Memorial HospitalUnknown statusPhase 4ketamine
Ketamine for Depression: An MRI StudyNCT02544607 · Massachusetts General HospitalCompletedPhase 4ketamine1
RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn PainNCT03305055 · Johns Hopkins UniversityTerminatedPhase 4ketamine1
Ketamine Co-induction for Patients With Major Depressive DisorderNCT03666494 · University of SaskatchewanUnknown statusPhase 4ketamine
Ketamine v. Ketorolac for Management of Generalized Tension Type HeadacheNCT03221569 · The Brooklyn Hospital CenterUnknown statusPhase 4ketamine1
Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol WithdrawalNCT02823977 · University of Colorado, DenverWithdrawnPhase 4ketamine1
Comparing Ketamine and Propofol Anesthesia for Electroconvulsive TherapyNCT01935115 · University of SaskatchewanCompletedPhase 4ketamine1
Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency WardNCT03216941 · Universidad Nacional de RosarioCompletedPhase 4ketamine1
Dexamethasone and Ketamine on Change of Postoperative MoodNCT03194594 · Wonkwang University HospitalCompletedPhase 4ketamine1
N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major DepressionNCT01260649 · Massachusetts General HospitalTerminatedPhase 4ketamine1
Treatment Study of Bipolar DepressionNCT00947791 · Icahn School of Medicine at Mount SinaiTerminatedPhase 4ketamine1
Intranasal Ketamine for Late-Life Depression and Suicidal IdeationNCT02295787 · Massachusetts General HospitalWithdrawnPhase 4ketamine
Ketamine For Suicidal IdeationNCT01507181 · James MurroughCompletedPhase 4ketamine1
Effects of Ketamine and Risperidone on CognitionNCT01140620 · University of ManchesterCompletedPhase 4ketamine3
Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major DepressionNCT02924090 · University of ManitobaUnknown statusPhase 4ketamine1
Clinical Trial of the Use of Ketamine in Treatment Resistant DepressionNCT02610712 · National Institute of Neurology and Neurosurgery, MexicoUnknown statusPhase 4ketamine1
The Use of Ketamine as an Anaesthetic During Electroconvulsive TherapyNCT01306760 · University of AberdeenCompletedPhase 4ketamine1
NMDA Antagonists in Bipolar DepressionNCT01833897 · New York State Psychiatric InstituteCompletedPhase 4ketamine1
D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant DepressionNCT02772211 · Sheba Medical CenterUnknown statusPhase 4ketamine1
A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn PatientsNCT02336308 · University of Colorado, DenverWithdrawnPhase 4ketamine1
Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive TherapyNCT02305394 · First Affiliated Hospital of Chongqing Medical UniversityUnknown statusPhase 4ketamine1

All records from ClinicalTrials.gov API v2, data build 2026-08-25. Registry records change between builds; the NCT number on each row links to the authoritative version.